The health and safety of our patients is, and always will be, our highest priority. We understand those living with growth hormone deficiency (GHD) and their loved ones may be facing a lot of uncertainty during this pandemic, and we are committed to keeping the communities we serve updated with any information that could help inform health decisions related to our medicines.
During these challenging times, if you are considering stopping or delaying your treatment, please speak with your doctor or healthcare team before doing so, as we recommend that personal treatment decisions should be made between you and your healthcare team. Your doctor will be able to assess the benefits and risks specific to your overall health situation.
If you have experienced a change in insurance or income, or seeking financial assistance or more information on your NUTROPIN treatment, including live virtual no-contact injection training, please call NURSE HOTLINE at 1-866-NUTROPIN (1-866-688-7674) to speak with a nurse or representative.
In addition to local public health guidance, or local guidance
specifically issued by medical or patient associations, please find
more information on Genentech’s response to the COVID-19 pandemic and
other support services on the Genentech website (https://www.gene.com/covid19).